Oncology

Equilab's services are meticulously designed to align with your study's specific requirements, ensuring seamless and successful trial execution, which includes:
 

• Rigorous PI and Site Selection
  We have established strong, long-term partnerships with some of the leading hospitals and specialized oncology centers across Indonesia. This access to top-tier sites and experienced Key Opinion Leaders (KOLs) ensures that your trial can tap into a large, diverse patient pool. Alongside with the sites, Equilab develops tailored patient recruitment strategies to overcome enrollment challenges and meet sponsor's project timelines.
   

• Specialized Pharmacovigilance and Safety Reporting
  The high-risk nature of many oncology treatments, including targeted and immunotherapies, requires robust and expedited safety reporting. Our dedicated pharmacovigilance team provides 24/7 medical monitoring and meticulous adverse event (AE) and serious adverse event (SAE) reporting to ensure the safety of every patient and maintain regulatory compliance. 
   

• Central Laboratory Services and Biomarker Analysis
  Modern oncology trials are heavily reliant on biomarkers. As a central laboratory, we handle the complex logistics of sample collection, processing, storage, and analysis. Our state-of-the-art facilities ensure the integrity of your valuable samples, supporting the critical biomarker and genomic testing necessary for today’s precision medicine trials.